PIONEER MEDICAL GROUP
ARDENTON WALK, BRISTOL
HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 16 | 20 | 80.0% | |
| HF 4 | 2011 | 17 | 23 | 73.9% | |
| HF 4 | 2012 | 13 | 17 | 76.5% | |
| HF 4 | 2013 | 15 | 16 | 93.8% | |
| HF004 | 2014 | 3 | 3 | 100.0% | |
| HF004 | 2015 | 3 | 3 | 100.0% | |
| HF004 | 2016 | 3 | 4 | 75.0% | |
| HF004 | 2017 | 11 | 12 | 91.7% | |
| HF004 | 2018 | 13 | 13 | 100.0% | |
| HF004 | 2019 | 25 | 26 | 96.2% | |
| HF004 | 2020 | 27 | 28 | 96.4% | |
| HF006 | 2021 | 27 | 30 | 90.0% | |
| HF006 | 2022 | 34 | 36 | 94.4% | |
| HF006 | 2023 | 130 | 140 | 92.9% |
